IP Verse

Pharmaceutical Works Polpharma Sa competitive analysis

Latest oppositions filed by Pharmaceutical Works Polpharma Sa

Explore patent oppositions filed by Pharmaceutical Works Polpharma Sa against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
EP1991267
Methods Of Treating Inflammatory And Autoimmune Diseases With NatalizumabBIOGEN IDEC MASep 20, 2018
EP2524060
Assay For Jc Virus AntibodiesBIOGEN IDEC MAAug 27, 2018
EP2645106
Methods And Products For Evaluating An Immune Response To A Therapeutic AgentBIOGEN IDEC MAMar 9, 2018
EP1734997
Steroid Sparing Agents And Methods Of Using SameBIOGEN IDEC MAJun 1, 2016
EP1944322
Treatment Of Tnf Alpha Related DisordersABBOTT BIOTECHNOLOGYDec 10, 2015
EP1872136
Methods And Products For Evaluating An Immune Response To A Therapeutic ProteinBIOGEN IDEC MANov 17, 2015

Latest PTAB cases involving Pharmaceutical Works Polpharma Sa

Discover the latest PTAB cases involving Pharmaceutical Works Polpharma Sa, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Pharmaceutical Works Polpharma Sa with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PHARMACEUTICAL WORKS POLPHARMA SA6 - - -
BIOGEN IDEC MA - 42 - 1
BIOGEN MA164 - 7
ELAN PHARMACEUTICALS - 9 - -